US Stock MarketDetailed Quotes

Lexaria Bioscience (LEXX)

Watchlist
  • 0.7588
  • +0.0279+3.82%
Close Jan 16 16:00 ET
  • 0.7111
  • -0.0477-6.29%
Post 18:00 ET
18.88MMarket Cap-1.33P/E (TTM)

Lexaria Bioscience (LEXX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
Total revenue
0
52.05%705.92K
107.14%174K
107.14%174K
20.00%174K
21.58%183.92K
105.24%464.28K
173.25%84K
8.10%84K
624.09%145K
Operating revenue
--0
52.34%705.92K
107.14%174K
107.14%174K
20.00%174K
22.31%183.92K
142.65%463.38K
100.64%84K
8.10%84K
624.09%145K
Cost of revenue
0
-43.59%2.72K
0
0
0
-43.59%2.72K
-84.69%4.82K
0
0
0
Gross profit
0
53.05%703.2K
107.14%174K
107.14%174K
20.00%174K
23.73%181.2K
135.97%459.46K
173.25%84K
29.31%84K
749.59%145K
Operating expense
-45.21%1.57M
102.56%12.58M
25.16%2.86M
114.81%3.92M
259.78%2.93M
123.39%2.87M
-7.67%6.21M
99.77%2.29M
-25.91%1.83M
-39.36%813.01K
Selling and administrative expenses
-1.79%902.29K
12.80%4.35M
-25.71%980.48K
-3.74%1.21M
118.45%1.24M
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
-11.99%567.23K
-General and administrative expense
-1.79%902.29K
12.80%4.35M
-25.71%980.48K
-3.74%1.21M
118.45%1.24M
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
-11.99%567.23K
Research and development costs
-65.63%671.34K
249.02%8.24M
94.59%1.88M
374.18%2.72M
585.95%1.69M
239.99%1.95M
-35.62%2.36M
93.28%967.21K
-65.07%573.09K
-64.70%245.78K
Operating profit
41.52%-1.57M
-106.51%-11.88M
-22.04%-2.69M
-115.18%-3.75M
-311.83%-2.75M
-136.20%-2.69M
11.95%-5.75M
-97.74%-2.2M
27.40%-1.74M
49.53%-668.01K
Net non-operating interest income expense
9.09%12
-78.92%3.02K
-59.73%2.82K
190
0
-99.85%11
-66.87%14.31K
-22.44%6.99K
0
-100.01%-1
Non-operating interest income
9.09%12
-78.92%3.02K
-59.73%2.82K
--190
--0
-99.85%11
-66.87%14.31K
-22.44%6.99K
--0
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--1
Other net income (expense)
-38.67%-22.09K
51.72%-33.71K
-220.49%-11.45K
2.46%-40.38K
122.88%34.04K
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
862.51%15.27K
Gain on sale of security
-38.67%-22.09K
51.72%-33.71K
-220.49%-11.45K
2.46%-40.38K
122.88%34.04K
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
862.51%15.27K
Income before tax
41.04%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
Income tax
1.79K
0
Net income
40.98%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
Net income continuous Operations
40.98%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
Minority interest income
14.78%-2.5K
27.92%-9.59K
21.95%-1.39K
42.19%-1.51K
-17.72%-3.76K
48.75%-2.93K
72.06%-13.31K
81.63%-1.78K
78.29%-2.62K
74.46%-3.19K
Net income attributable to the parent company
41.01%-1.6M
-105.37%-11.9M
-23.39%-2.7M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
49.96%-649.54K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.01%-1.6M
-105.37%-11.9M
-23.39%-2.7M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
49.96%-649.54K
Basic earnings per share
56.25%-0.07
-40.43%-0.66
13.33%-0.13
-61.54%-0.21
-150.00%-0.15
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
72.73%-0.06
Diluted earnings per share
56.25%-0.07
-40.43%-0.66
13.33%-0.13
-61.54%-0.21
-150.00%-0.15
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
72.73%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024
Total revenue 052.05%705.92K107.14%174K107.14%174K20.00%174K21.58%183.92K105.24%464.28K173.25%84K8.10%84K624.09%145K
Operating revenue --052.34%705.92K107.14%174K107.14%174K20.00%174K22.31%183.92K142.65%463.38K100.64%84K8.10%84K624.09%145K
Cost of revenue 0-43.59%2.72K000-43.59%2.72K-84.69%4.82K000
Gross profit 053.05%703.2K107.14%174K107.14%174K20.00%174K23.73%181.2K135.97%459.46K173.25%84K29.31%84K749.59%145K
Operating expense -45.21%1.57M102.56%12.58M25.16%2.86M114.81%3.92M259.78%2.93M123.39%2.87M-7.67%6.21M99.77%2.29M-25.91%1.83M-39.36%813.01K
Selling and administrative expenses -1.79%902.29K12.80%4.35M-25.71%980.48K-3.74%1.21M118.45%1.24M29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M-11.99%567.23K
-General and administrative expense -1.79%902.29K12.80%4.35M-25.71%980.48K-3.74%1.21M118.45%1.24M29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M-11.99%567.23K
Research and development costs -65.63%671.34K249.02%8.24M94.59%1.88M374.18%2.72M585.95%1.69M239.99%1.95M-35.62%2.36M93.28%967.21K-65.07%573.09K-64.70%245.78K
Operating profit 41.52%-1.57M-106.51%-11.88M-22.04%-2.69M-115.18%-3.75M-311.83%-2.75M-136.20%-2.69M11.95%-5.75M-97.74%-2.2M27.40%-1.74M49.53%-668.01K
Net non-operating interest income expense 9.09%12-78.92%3.02K-59.73%2.82K1900-99.85%11-66.87%14.31K-22.44%6.99K0-100.01%-1
Non-operating interest income 9.09%12-78.92%3.02K-59.73%2.82K--190--0-99.85%11-66.87%14.31K-22.44%6.99K--0----
Non-operating interest expense --------------------------------------1
Other net income (expense) -38.67%-22.09K51.72%-33.71K-220.49%-11.45K2.46%-40.38K122.88%34.04K70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K862.51%15.27K
Gain on sale of security -38.67%-22.09K51.72%-33.71K-220.49%-11.45K2.46%-40.38K122.88%34.04K70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K862.51%15.27K
Income before tax 41.04%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K
Income tax 1.79K0
Net income 40.98%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K
Net income continuous Operations 40.98%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K
Minority interest income 14.78%-2.5K27.92%-9.59K21.95%-1.39K42.19%-1.51K-17.72%-3.76K48.75%-2.93K72.06%-13.31K81.63%-1.78K78.29%-2.62K74.46%-3.19K
Net income attributable to the parent company 41.01%-1.6M-105.37%-11.9M-23.39%-2.7M-112.67%-3.79M-317.71%-2.71M-129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M49.96%-649.54K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.01%-1.6M-105.37%-11.9M-23.39%-2.7M-112.67%-3.79M-317.71%-2.71M-129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M49.96%-649.54K
Basic earnings per share 56.25%-0.07-40.43%-0.6613.33%-0.13-61.54%-0.21-150.00%-0.15-23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.1372.73%-0.06
Diluted earnings per share 56.25%-0.07-40.43%-0.6613.33%-0.13-61.54%-0.21-150.00%-0.15-23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.1372.73%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More